Open Access

Molecular characterization and immune modulation properties of Clonorchis sinensis-derived RNASET2

Parasites & Vectors20136:360

https://doi.org/10.1186/1756-3305-6-360

Received: 4 September 2013

Accepted: 18 December 2013

Published: 23 December 2013

Abstract

Background

Clonorchis sinensis (C. sinensis, Cs) is a trematode parasite that often causes chronic cumulative infections in the hepatobiliary ducts of the host and can lead to pathological changes by continuously released excretory/secretory proteins (ESPs). A T2 ribonuclease in trematode ESPs, has been identified as a potent regulator of dendritic cell (DCs) modulation. We wondered whether there was a counterpart present in Cs ESPs with similar activity. To gain a better understanding of Cs ESPs associated immune responses, we identified and characterized RNASET2 of C. sinensis (Cs RNASET2) in this paper.

Methods

We expressed Cs RNASET2 in Pichia pastoris and identified its molecular characteristics using bioinformatic analysis and experimental approaches. The immune modulation activities of Cs RNASET2 were confirmed by evaluating cytokine production and surface markers of recombinant Cs RNASET2 (rCs RNASET2) co-cultured DCs, and monitoring levels of IgG isotypes from rCs RNASET2 administered BALB/c mice.

Results

Cs RNASET2 appeared to be a glycoprotein of T2 ribonuclease family harboring conserved CAS motifs and rich in B-cell epitopes. Furthermore, Cs RNASET2 was present in Cs ESPs and was able to modulate cytokine production of DCs. In addition, rCs RNASET2 could significantly suppress the expression of lipopolysaccharide-induced DCs maturation markers. In addition, when subcutaneously administered with rCs RNASET2 there was a marked effect on IgG isotypes in mouse sera.

Conclusion

Collectively, we revealed that Cs RNASET2, a T2 ribonuclease present in Cs ESPs, could modulate DCs maturation and might play an important role in C. sinensis associated immune regulation in the host.

Keywords

Clonorchis sinensis RNASET2T2 ribonucleaseExcretory/secretory productDendritic cellImmune modulation

Background

Clonorchiasis, caused by the infection of Clonorchis sinensis (C. sinensis), is highly epidemic in several Asian countries. More than 35 million people are infected with C. sinensis globally [1]. Clonorchiasis is predominantly caused by ingesting raw or undercooked freshwater fish harboring metacercariae [2]. When ingested by the host, larvae excyst in the duodenum and then migrate into the peripheral intrahepatic bile ducts to develop as adult worms [3]. C. sinensis adult worms can thrive for more than 10 years in humans [4]. People infected with C. sinensis are often asymptomatic, however, repeated and chronic infections can eventually lead to various hepatobiliary symptoms and complications. During the long term of parasitism, the liver flukes continuously release excretory/secretory proteins (ESPs), a cocktail of hundreds to thousands of bioactive proteins. Prior studies have demonstrated that the components of ESPs from C. sinensis (Cs ESPs) are implicated in biological processes especially the induction of host immune response [5], which may be intimately associated with formation of cholangitis, liver cirrhosis and cholangiocarcinoma (CCA) [6]. Owing to its carcinogenicity, C. sinensis has been regarded as a group I carcinogen of cholangiocarcinoma [7].

T2 ribonucleases are transferase-type RNase and distribute broadly in almost all groups of living organisms including bacteria, fungi, virus, plants, and animals [8]. All of these enzymes have diverse biological activities, such as degradation of self-RNA, clearance of nucleic acids, serving as extra- or intracellular cytotoxins, and regulation of host immune responses [810]. Numerous studies have been conducted to characterize the biochemical properties and immunoregulatory roles of a T2 ribonuclease (omega-1) in Schistosoma mansoni (Sm omega-1), which is present in soluble egg antigens (SEA) of S. mansoni, formed by egg released ESPs [1113]. Sm omega-1 could trigger Th2 response by modulating dendritic cells (DCs) phenotype, structure and protein synthesis [1416]. Moreover, Sm omega-1 has been reported to induce priming of Foxp3+ Tregs, which play crucial immunoregulatory roles in the process of S. mansoni infection [17]. Interestingly, the function of Sm omega-1 to enhance Foxp3 expression also depends on the alteration of DCs. These findings illustrate that Sm omega-1 is a key component of ESPs to modulate host immune responses, which is elicited by DCs alteration. DCs are defined as professional antigen-presenting cells serving as the sentinels of the immune system and have the unique capacity to induce and coordinate both innate and adaptive immune responses [1822]. These findings give us insight into interactions between a secreted antigen and DCs, leading us to gain a better understanding of helminth associated immune responses.

In the present study, we expressed and characterized C. sinensis RNASET2 (Cs RNASET2). We investigated the effects of rCs RNASET2 on bone marrow derived dendritic cell (BMDCs) modulation. In addition, we evaluated humoral immune responses initiated by rCs RNASET2 in BALB/c mice. Based on these observations, we proposed that Cs RNASET2 was intimately associated with C. sinensis-triggered immune response in the host.

Methods

Animals

Female 6- to 8-week-old BALB/c mice and SD rats were obtained from the animal center of Sun Yat-Sen University (Guangzhou, China). The animals were housed in a pathogen-free facility. All animal experiments were conducted under Animal Care and Use Committee of Sun Yat-sen University (Permit No: SCXK (Guangdong) 2009–0011).

Sequence analysis of Cs RNASET2

The full-length encoding sequence of Cs RNASET2 [Accession No. GAA50115.1] was downloaded from GenBank in NCBI [http://www.ncbi.nlm.nih.gov/]. Homology analysis was performed using the blastx program [http://blast.ncbi.nlm.nih.gov/]. The molecular characteristics and the functional domains of Cs RNASET2 were assessed using proteomics tools provided by Expasy website [http://www.expasy.org/]. The alignments of the deduced amino acid sequence and T2 amino acid sequences from other species were performed by the software Vector NTI suite 8.0.

Preparation of antigens and polyclonal antibodies

Recombinant Cs RNASET2 was expressed in P. pastoris according to the manufacturer’s protocol (Invitrogen, USA). RNase activity of rCs RNASET2 was identified, and deglycosylation assay of the protein was carried out with PNGase F (New England BioLabs, USA). We collected Cs ESPs referring to the protocol as previously described [23]. Each BALB/c mouse was immunized subcutaneously with 100 μg rCs RNASET2 or ESPs, which were respectively emulsified with complete Freund’s adjuvant at the first injection. Two booster injections at 2-week intervals were performed with 50 μg of proteins, which were emulsified with incomplete Freund’s adjuvant. After 2 weeks of the final boosting, anti-sera were collected and antibody titers were determined by ELISA. All anti-sera samples were split and stored at - 80°C.

Western blotting

rCs RNASET2 and Cs ESPs were subjected to 12% SDS-PAGE, and subsequently electrotransferred onto the PVDF membranes (Millipore, USA) for 1 h at 100 V. The membranes were then blocked with 5% skimmed milk in PBS for 2 h at room temperature, and incubated with myc-epitope monoclonal antibody (1:1000 dilutions), his-tag monoclonal antibody, mouse anti-rCs RNASET2 sera (1:2000 dilutions), mouse anti- ESPs sera, naïve mouse and C. sinensis-infected mouse sera (1:100 dilutions) respectively. The membranes were then incubated with peroxidase-conjugated goat anti-mouse IgG (Proteintech, USA, 1:10,000 dilutions) for 1 h at room temprature. The reactions were visualized by enhanced chemiluminescence (ECL) method.

Generation and stimulation of bone marrow derived dendritic cells

Femurs were obtained from BALB/c mice and the muscle tissues were removed with scissors. The bone marrow cells (BMCs) were isolated by flushing the bone marrow with chilled RPMI-1640 medium. Red blood cells were lysed with red blood cell lysing buffer (Sigma, USA). The remaining BMCs were washed twice and then resuspended into 2 × 106/ml. BMCs were cultured in complete RPMI-1640 supplemented with 20 ng/ml mouse GM-CSF (R&D Systems, USA) and 10 ng/ml mouse IL-4 (R&D Systems). On days 3 and 5, fresh culture medium including the supplements were added. Immature BMDCs were harvested on day 7 and stimulated with or without different concentrations of rCs RNASET2 (0.05-50 μg/ml) or ESPs (10–160 μg/ml) in the presence of 1 μg/ml LPS (sigma) for 12, 24 and 48 h. Generally, Th1- and Th2-polarizing Ag stimulate DCs via discrete pathways, coupled with distinct modifications of the DC maturation. Therefore, we utilized rCs FABP, a protein has been reported to induce Th1 immune responses, as a control protein [24, 25].

Flow cytometry

Surface markers on pretreated BMDCs were detected by FCM using the following mAbs: FITC labeled anti-CD11c (eBioscience, USA), PE labeled anti-CD80, anti-CD86, APC labeled anti-CD40 (BD PharMingen, USA). For staining, BMDCs were washed twice with PBS containing 0.1% BSA and 0.05% sodium azide. The cells were thereafter incubated with the respective mAbs for 30 min at 4°C in the dark. Then, cells were washed twice and resuspended in PBS. Flow cytometry was performed on a Beckman Coulter Gallios cytometer and analyzed using the Kaluza software (Beckman Coulter, USA).

ELISA

Cell-free supernatants were harvested at different time points after stimulation, and levels of IL-12p70 and IL-10 were assessed by commercially available ELISA kits (eBioscience) according to the manufacturer’s protocol. Sera were collected from rCs RNASET2 immunized mice or PBS immunized mice at 4 and 6 weeks after primary injection. Levels of IgG1 and IgG2a in sera were evaluated by ELISA coated with 100 μl 5 μg/ml rCs RNASET2 each well overnight at 4°C. ELISA plates were blocked with 5% skimmed milk for 2 h at 37°C and then incubated with sera for 2 h at 37°C. Subsequently, the plates were incubated with HRP-conjugated goat anti-mouse IgG1 and IgG2a (invitrogen) for 1 h at 37°C. The optical density was tested at 450 nm.

Statistical analysis

Data were routinely analyzed by the GraphPad Prism 5 software. The Mann–Whitney test was performed to calculate statistical significance of differences between two groups of observations. p -Values < 0.05 were considered statistically significant.

Results

Sequence analysis of Cs RNASET2

The complete coding sequence of Cs RNASET2 contained 690 bp encoding a putative protein of 229 amino acids with the predicted molecular weight of 26.6 kDa. The hypothetical pI of the deduced protein was 5.65. The estimated half-life of Cs RNASET2 was more than 20 hours in yeast and more than 10 hours in E. coli. The instability index of the deduced protein was 35.40, indicating Cs RNASET2 might be a stable protein. Blastx analysis showed that the sequence was a glycoprotein of the T2 ribonuclease family, which contained two critical histidine residues in the CAS motifs. However, the sequence just shared 43% and 39% identity with its homologues from S. janpani and S. mansoni, and it was rich in B-cell epitopes, which might suggest Cs RNASET2 as being a good immunogen (Figure 1).
Figure 1

Sequence alignment of RNASET2 from C. sinensis with homologues from other species. The identical amino acids of all aligned sequences are shaded in black. The conserved ribonuclease T2 CAS I and CAS II domains are marked with box1 and box2. Two highly conserved histidine residues in the CAS regions are indicated by black triangles. A N-linked glycosylation site is marked with box3 and an arrow. The B cell epitopes are labeled by dots. GenBank Accession Numbers: C.s, Clonorchis sinensis, [GAA50115.1]; S.j, Schistosoma japonicum, [AAW26577.1]; S.m, Schistosoma mansoni, [ABB73003.1]; F.c, Felis catus, [XP_003986767.1]; H.s, Homo sapiens, [AAH51912.1]; M.u, mus musculus, [AAI00331.1]; R.a, rattus norvegicus, [NP_001099680.1].

Identification of Cs RNASET2 as a component of C. Sinensis ESPs

We successfully expressed rCs RNASET2 (Additional file 1: Figure S1A) and identified its c-myc epitope and his-tag by western blot (Additional file 1: Figure S1B). The RNase activity of rCs RNASET2 was determined (Additional file 1: Figure S2). We noted that deglycosylated rCs RNASET2 displayed ~4 kDa reduction of molecular weight (Figure 2A). In addition, rCs RNASET2 could be probed by anti-Cs RNASET2, anti-Cs ESPs and C. sinensis-infected mouse sera at a prominent single band around 35 kDa, whereas the protein could not be recognized by sera from naïve mice. In addition, Cs ESPs reacted with mouse anti-Cs RNASET2 sera at a single band around 27 kDa (Figure 2B). These results indicated that rCs RNASET2 was indeed a component of Cs ESPs with glycosylation and RNase activity.
Figure 2

Determination of Cs RNASET2 as a component of C. Sinensis ESPs. (A) The deglycosylation assay of rCs RNASET2 was evaluated by SDS-PAGE protein molecular weight markers (M); untreated rCs RNASET2 (lane 1); Cs ESPs (lane 2); rCs RNASET2 incubated with PNGase F deglycosylation enzyme (lane 3). (B) Western blotting analysis of rCs RNASET2. The rCs RNASET2 reacted with sera from mice infected with C. sinensis (lane 1); mice immunized with rCs RNASET2 (lane 2), mice immunized with Cs ESPs (lane 3) and naïve mouse (lane 4); Cs ESPs reacted with sera from mice immunized with rCs RNASET2 (lane 5). One of four independent experiments is shown.

Cytokine production of BMDCs in response to rCs RNASET2

IL-12p70 and IL-10 are potent adjustive cytokines in the immune system, which can be secreted by DCs [26, 27]. We incubated BMDCs with LPS in the presence or absence of various concentrations of rCs RNASET2, ESP or 0.5 μg/ml rCs FABP. We found that both rCs RNASET2 and Cs ESPs suppressed the LPS-induced up-regulation of IL-12p70 on BMDCs in a dose-dependent manner at the indicated time points (Figure 3A). In contrast, Cs ESPs (20–80 μg/ml) enhanced the expression of IL-10 in a dose-dependent manner, and rCs RNASET2 could promote IL-10 synthesis only at a concentration of 0.5 μg/ml (Figure 3B). In addition, rCs FABP could not obviously interfere with the cytokine production of DCs.
Figure 3

Cytokine production by BMDCs in response to r Cs RNASET2. BMDCs (2 × 106/ml) were incubated with 1 μg/ml LPS in the presence or absence of various concentrations of (10, 20, 40, 80 and 160 μg/ml) ESPs, (0.05, 0.5, 5 and 50 μg/ml) rCs RNASET2 or (0.5 μg/ml) rCs FABP. Supernatants were harvested at different time points after stimulation and evaluated by ELISA for expression of IL-12p70 (A) and IL-10 (B). Error bars represent mean cytokine concentrations ± SD (n = 5). Statistical significance was analyzed by the Mann–Whitney test (*p < 0.05, **p < 0.01, ns: not significant).

Effects of rCs RNASET2 on BMDCs phenotypic modifications

A previous study has demonstrated that helminth antigens can affect the maturation of DCs [28]. To confirm the effects of Cs RNASET2 on DCs maturation, BMDCs were treated with LPS in the presence or absence of rCs RNASET2, rCs FABP (control protein) or ESPs for 24 h, and a series of surface markers expressed on DCs were assessed. In the presence of LPS alone, the expression levels of CD11c, CD40, CD80 and CD86 on BMDCs were raised, when rCs RNASET2 or ESPs were added, the LPS-triggered up-regulation of surface markers was strikingly reduced. In contrast, rCs FABP had no significant effect on the expression of these surface markers (Figure 4A, B).
Figure 4

Modulation of BMDCs maturation elicited by r Cs RNASET2. (A) Days-7 BMDCs (2 × 106/ml) were stimulated with or without 0.5 μg/ml rCs RNASET2, 0.5 μg/ml rCs FABP or 40 μg/ml ESPs in the presence of 1 μg/ml LPS for 24 h. The levels of CD11c, CD40, CD80 and CD86 on BMDCs were detected by flow cytometry. Values stand for the percentage of treated cells staining positive for the indicated marker. Histograms are representative of seven independent experiments. (B) Statistical results of the expression of surface markers on BMDCs. Data are expressed as mean ± SD. Statistical significance was analyzed by the Mann–Whitney test (*p < 0.05, **p < 0.01, ns: not significant).

IgG isotype analysis of rCs RNASET2 immunized mice

For mice, the IgG1 response generally represents Th2-activity, while IgG2a represents Th1-activity [29]. We evaluated the levels of IgG1 and IgG2a in sera obtained from rCs RNASET2 immunized mice. The data shown in Figure 5 shows that administration of rCs RNASET2 triggered a markedly higher IgG1 expression than IgG2a compared with control mice at week 4 (1.99 ± 0.12 versus 0.26 ± 0.04, p < 0.0001) and week 6 (2.88 ± 0.22 versus 0.49 ± 0.31, p = 0.0002).
Figure 5

IgG subclass responses triggered by r Cs RNASET2. BALB/c mice (n = 6) were immunized s.c. with rCs RNASET2. After 4 (A) and 6 (B) weeks, sera levels of IgG1 and IgG2a specific for rCs RNASET2 were evaluated by ELISA. IgG1 levels were significantly higher than IgG2a at both 4th and 6th week. Error bars represent mean levels ± SD. Statistical significance was analyzed by the Mann–Whitney test (***p < 0.0005).

Discussion

It is well demonstrated that DCs are dominant players in the initiation and sustenance of immune responses [1922]. In general, DCs undergo activation, termed maturation, upon recognition of invading pathogens, such as viruses, bacteria, and fungi. In the process of maturation, DCs up-regulate the production of surface markers and polarizing cytokines [20, 21]. However, recent studies have indicated that DCs exposed to antigens derived from parasitic helminths fail to induce the classical DC activation [3032]. The maturation status of DCs is crucial for the initiation of primary immune responses. It has been documented that Sm omega-1, a RNase T2 family glycoprotein present in ESP, is a major molecule to dramatically modulate the maturation of DCs in S. mansoni infections [1417].

Since Sm omega-1 has been reported to play a potent role in the process of DCs modulation, we wondered whether there was a counterpart present in Cs ESPs with similar activity. In this study, we firstly identified a gene encoding Cs RNASET2, which also appeared to be a glycoprotein of RNase T2 family. All RNase T2 enzymes have two blocks of conserved amino acids (termed CAS I and CAS II) [8, 9]. These regions have typical catalytic residue of one to three histidine residues [8, 33]. Sequence analysis showed that Cs RNASET2 indeed harbored the two conserved CAS I and CAS II regions with two critical histidine residues (Figure 1). It suggested that Cs RNASET2 was the counterpart of Sm omega-1. We expressed rCs RNASET2 in P. pastoris with RNase activity. Deglycosylation experiment displayed ~4 kDa size reduction of the rCs RNASET2 (Figure 2A), which indicated the rCs RNASET2 was indeed glycosylated. rCs RNASET2 could react with C. sinensis-infected mouse sera and ESPs immunized mouse sera, meanwhile, ESPs could be probed with mouse anti-rCs RNASET2 sera at a single band (Figure 2B). These results revealed that Cs RNASET2 was indeed a component of Cs ESPs, which are in accordance with the fact that the RNase T2 family members are typically secreted [9, 34]. The difference of 8 kDa in molecular weight between rCs RNASET2 and the native protein in ESP might be due to his/myc-tag, a minor imprecision on SDS-PAGE assays and glycosylation (~4 kDa reduction). Meanwhile, we performed western blot analysis, in which ESP reacted with anti-rCs RNASET2 and anti-ESP mouse sera. Gradation analysis revealed that Cs RNASET2 took up about 2% of ESP (Additional file 1: Figure S3).

Furthermore, ELISA assays revealed that the LPS-induced up-regulation of IL-12p70 on BMDCs decreased in a dose-dependent manner in the presence of various concentrations of rCs RNASET2 or Cs ESP (Figure 3A). In contrast, Cs ESPs (20–80 μg/ml) enhanced the expression of IL-10 in a dose-dependent manner, and rCs RNASET2 could promote IL-10 synthesis only at a concentration of 0.5 μg/ml. Higher concentrations of rCs RNASET2 or ESP failed to promote IL-10 production (Figure 3B). We then performed BMDCs survival assay with Cell Counting kit-8 (CCK8) under different concentrations of rCs RNASET2 or ESP, and observed that higher concentrations of rCs RNASET2 or ESP could inhibit cell viability (Additional file 1: Figure S4). Therefore, we finally chose 0.5 μg/ml of rCs RNASET2 and 40 μg/ml of ESP as moderate working concentrations. Cs FABP, a Th1-polarizing Ag, was utilized to be a control protein. There was no significant difference of cytokine production levels when rCs FABP was added. Subsequently, we carried out flow cytometry analysis and noted that levels of surface markers including CD11C, CD40, CD80 and CD86 on rCs RNASET2- or Cs ESP-treated BMDCs significantly decreased compared with LPS controls, whereas rCs FABP displayed little effect on these surface makers expression (Figure 4). These results demonstrated that rCs RNASET2 could modulate the cytokine production and maturation of DCs. Interleukin-12 (IL-12) plays the key role in the generation of Th1 cells. IL-12p70 is a heterodimeric cytokine composed of two chains (p35 and p40), which is able to stimulate NK cells and T cells to produce IFN-γ to resist against pathogens [35]. It has been well established that IL-10 is a cytokine secreted by CD4+ T cells belonging to the Th2 subset, which has been determined to suppress the production of IFN-γ. The induction of IL-10 may be an important strategy by which parasites evade IFN-γ-dependent, cell-mediated immune destruction [36]. Our experiments showed diminished expression of IL-12p70 and increased expression of IL-10 in rCs RNASET2-cocultured DCs. Therefore, it is conceivable that rCs RNASET2 co-cultured DCs may suppress Th1 polarization, which is eventually beneficial for C. sinensis escaping from the host immunity.

IgG2a and IgGl immunoglobulin isotypes are generally regarded as markers for Th1 and Th2 responses respectively [29, 37]. Our studies demonstrated that the up-regulation of IgG1 was greater than that of IgG2a (Figure 5), confirming that Th2 responses might be dominant in rCs RNASET2 immunized mice. These results were in agreement with the data obtained from rCs RNASET2 co-incubated BMDCs, as reduced expression of IL-12p70 and increased production of IL-10 could inhibit Th1 polarization. However, it is difficult to determine the dominance of Th1 or Th2 responses on the basis of IgG isotypes alone, because the initiation of B cell isotype switching is not only confined to the mutual effects of Th1 and Th2 cytokines. Further studies are required to determine whether Cs RNASET2 is able to trigger Th2 or Treg responses through DCs modulation, whether this function is associated with its RNase activity, and which pathways are involved in the process.

Conclusion

Collectively, we cloned and identified Cs RNASET2 as a molecule present in C. sinensis ESPs. We confirmed that rCs RNASET2 could regulate the host immune response via modulating DCs maturation, as well as production of IL-12p70 and IL-10. We also observed that administration of rCs RNASET2 to mice could alter the IgG1/IgG2a ratio. It will be of significant interest to investigate whether Cs RNASET2 is able to initiate Th2 or Treg responses through modulating DCs, which will pave the way towards unraveling the regulatory mechanisms of the immune responses in C. sinensis infection and may provide potential therapeutic tools.

Declarations

Acknowledgments

This work was supported by grants from the National Key Basic Research and Development Project of China (973 project; No.2010CB530000), the National Important Sci-tech Special Projects (No. 2012ZX10004220), National Natural Science Foundation of China (No. 81101270 and No. 81171602), the Fundamental Research Funds for the Central Universities (No. 3164015) and Sun Yat-sen University graduate student funding for abroad visiting and international cooperation research projects.

Authors’ Affiliations

(1)
Department of Parasitology, Zhongshan School of Medicine, Sun Yat-sen University
(2)
Key Laboratory for Tropical Diseases Control, Ministry of Education, Sun Yat-sen University
(3)
National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention

References

  1. Lin RQ, Tang JD, Zhou DH, Song HQ, Huang SY, Chen JX, Chen MX, Zhang H, Zhu XQ, Zhou XN: Prevalence of Clonorchis sinensis infection in dogs and cats in subtropical southern China. Parasit Vectors. 2011, 4: 180-PubMed CentralView ArticlePubMedGoogle Scholar
  2. Chen J, Xu MJ, Zhou DH, Song HQ, Wang CR, Zhu XQ: Canine and feline parasitic zoonoses in China. Parasit Vectors. 2012, 5: 152-PubMed CentralView ArticlePubMedGoogle Scholar
  3. Kim HG, Han J, Kim MH, Cho KH, Shin IH, Kim GH, Kim JS, Kim JB, Kim TN, Kim TH, Kim TH, Kim JW, Ryu JK, Moon YS, Moon JH, Park SJ, Park CG, Bang SJ, Yang CH, Yoo KS, Yoo BM, Lee KT, Lee DK, Lee BS, Lee SS, Lee SO, Lee WJ, Cho CM, Joo YE, Cheon GJ: Prevalence of clonorchiasis in patients with gastrointestinal disease: a Korean nationwide multicenter survey. World J Gastroenterol. 2009, 15: 86-94.PubMed CentralView ArticlePubMedGoogle Scholar
  4. Keiser J, Utzinger J: Food-borne trematodiases. Clin Microbiol Rev. 2009, 22: 466-483.PubMed CentralView ArticlePubMedGoogle Scholar
  5. Lei HL, Tian YL, Chen WJ, Wang XY, Li XR, Mao Q, Sun JF, Li R, Xu YQ, Liang C, Huang Y, Yu XB: The biochemical and immunological characterization of two serpins from Clonorchis sinensis. Mol Biol Rep. 2013, 40: 3977-3985.View ArticlePubMedGoogle Scholar
  6. Qian MB, Chen YD, Fang YY, Xu LQ, Zhu TJ, Tan T, Zhou CH, Wang GF, Jia TW, Yang GJ, Zhou XN: Disability weight of Clonorchis sinensis infection: captured from community study and model simulation. PLoS Negl Trop Dis. 2011, 5: e1377-PubMed CentralView ArticlePubMedGoogle Scholar
  7. Fried B, Reddy A, Mayer D: Helminths in human carcinogenesis. Cancer Lett. 2011, 305: 239-249.View ArticlePubMedGoogle Scholar
  8. Luhtala N, Parker R: T2 Family ribonucleases: ancient enzymes with diverse roles. Trends Biochem Sci. 2010, 35: 253-259.PubMed CentralView ArticlePubMedGoogle Scholar
  9. Deshpande RA, Shankar V: Ribonucleases from T2 family. Crit Rev Microbiol. 2002, 28: 79-122.View ArticlePubMedGoogle Scholar
  10. Schwartz B, Shoseyov O, Melnikova VO, McCarty M, Leslie M, Roiz L, Smirnoff P, Hu GF, Lev D, Bar-Eli M: ACTIBIND, a T2 RNase, competes with angiogenin and inhibits human melanoma growth, angiogenesis and metastasis. Cancer Res. 2007, 67: 5258-5266.View ArticlePubMedGoogle Scholar
  11. Dunne DW, Jones FM, Doenhoff MJ: The purification, characterization, serological activity and hepatotoxic properties of two cationic glycoproteins (alpha 1 and omega 1) from Schistosoma mansoni eggs. Parasitology. 1991, 103: 225-236.View ArticlePubMedGoogle Scholar
  12. Fitzsimmons CM, Schramm G, Jones FM, Chalmers IW, Hoffmann KF, Grevelding CG, Wuhrer M, Hokke CH, Haas H, Doenhoff MJ, Dunne DW: Molecular characterization of omega-1: a hepatotoxic ribonuclease from Schistosoma mansoni eggs. Mol Biochem Parasitol. 2005, 144: 123-127.View ArticlePubMedGoogle Scholar
  13. Meevissen MH, Wuhrer M, Doenhoff MJ, Schramm G, Haas H, Deelder AM, Hokke CH: Structural characterization of glycans on omega-1, a major Schistosoma mansoni egg glycoprotein that drives Th2 responses. J Proteome Res. 2010, 9: 2630-2642.View ArticlePubMedGoogle Scholar
  14. Everts B, Hussaarts L, Driessen NN, Meevissen MH, Schramm G, van der Ham AJ, van der Hoeven B, Scholzen T, Burgdorf S, Mohrs M, Pearce EJ, Hokke CH, Haas H, Smits HH, Yazdanbakhsh M: Schistosome-derived omega-1 drives Th2 polarization by suppressing protein synthesis following internalization by the mannose receptor. J Exp Med. 2012, 209: 1753-1767.PubMed CentralView ArticlePubMedGoogle Scholar
  15. Everts B, Perona-Wright G, Smits HH, Hokke CH, van der Ham AJ, Fitzsimmons CM, Doenhoff MJ, van der Bosch J, Mohrs K, Haas H, Mohrs M, Yazdanbakhsh M, Schramm G: Omega-1, a glycoprotein secreted by Schistosoma mansoni eggs, drives Th2 responses. J Exp Med. 2009, 206: 1673-1680.PubMed CentralView ArticlePubMedGoogle Scholar
  16. Steinfelder S, Andersen JF, Cannons JL, Feng CG, Joshi M, Dwyer D, Caspar P, Schwartzberg PL, Sher A, Jankovic D: The major component in schistosome eggs responsible for conditioning dendritic cells for Th2 polarization is a T2 ribonuclease (omega-1). J Exp Med. 2009, 206: 1681-1690.PubMed CentralView ArticlePubMedGoogle Scholar
  17. Zaccone P, Burton OT, Gibbs SE, Miller N, Jones FM, Schramm G, Haas H, Doenhoff MJ, Dunne DW, Cooke A: The S. mansoni glycoproteinω-1 induces Foxp3 expression in NOD mouse CD4+T cells. Eur J Immunol. 2011, 41: 2709-2718.View ArticlePubMedGoogle Scholar
  18. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature. 1998, 392: 245-252.View ArticlePubMedGoogle Scholar
  19. Steinman RW, Hawiger D, Nussenzweig MC: Tolerogenic dendritic cells. Annu Rev Immunol. 2003, 21: 685-711.View ArticlePubMedGoogle Scholar
  20. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K: Immunobiology of dendritic cells. Annu Rev Immunol. 2000, 18: 767-811.View ArticlePubMedGoogle Scholar
  21. Lipscomb MF, Masten BJ: Dendritic cells: immune regulators in health and disease. Physiol Rev. 2002, 82: 97-130.View ArticlePubMedGoogle Scholar
  22. Morelli AE, Thomson AW: Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol. 2007, 7: 610-621.View ArticlePubMedGoogle Scholar
  23. Chen WJ, Wang XY, Li XR, Lv XL, Zhou CH, Deng CH, Lei HL, Men JT, Fan YX, Lian C, Yu XB: Molecular characterization of cathepsin B from Clonorchis sinensis excretory/secretory products and assessment of its potential for serodiagnosis of clonorchiasis. Parasit Vectors. 2011, 4: 149-PubMed CentralView ArticlePubMedGoogle Scholar
  24. Cervi L, MacDonald AS, Kane C, Dzierszinski F, Pearce EJ: Cutting edge: dendritic cells copulsed with microbial and helminth antigens undergo modified maturation, segregate the antigens to distinct intracellular compartments, and concurrently induce microbe-specific Th1 and helminth-specific Th2 responses. J Immunol. 2004, 172: 2016-2020.View ArticlePubMedGoogle Scholar
  25. Lee JS, Kim IS, Sohn WM, Lee J, Yong TS: A DNA Vaccine Encoding a Fatty Acid-Binding Protein of Clonorchis sinensis Induces Protective Immune Response in Sprague–Dawley Rats. Scand J Immunol. 2006, 63: 169-176.View ArticlePubMedGoogle Scholar
  26. Trinchieri G, Pflanz S, Kastelein RA: The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity. 2003, 19: 641-644.View ArticlePubMedGoogle Scholar
  27. Moore KW, de Waal MR, Coffman RL, O’Garra A: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001, 19: 683-765.View ArticlePubMedGoogle Scholar
  28. Everts B, Smits HH, Hokke CH, Yazdanbakhsh M: Helminths and dendritic cells: sensing and regulating via pattern recognition receptors, Th2 and Treg responses. Eur J Immunol. 2010, 40: 1525-1537.View ArticlePubMedGoogle Scholar
  29. Mountford AP, Fisher A, Wilson RA: The profile of lgGl and IgG2a antibody responses in mice exposed to Schistosoma mansoni. Parasite Immunol. 1994, 16: 521-527.View ArticlePubMedGoogle Scholar
  30. Jeong YI, Kim SH, Ju JW, Cho SH, Lee WJ, Park JW, Park YM, Lee SE: Clonorchis sinensis-derived total protein attenuates airway inflammation in murine asthma model by inducing regulatory T cells and modulating dendritic cell functions. Biochem Biophys Res Commun. 2011, 407: 793-800.View ArticlePubMedGoogle Scholar
  31. MacDonald AS, Straw AD, Bauman B, Pearce EJ: CD8- dendritic cell activation status plays an integral role in influencing Th2 response development. J Immunol. 2001, 167: 1982-1988.View ArticlePubMedGoogle Scholar
  32. MacDonald AS, Straw AD, Dalton NM, Pearce EJ: Cutting edge: Th2 response induction by dendritic cells: a role for CD40. J Immunol. 2002, 168: 537-540.View ArticlePubMedGoogle Scholar
  33. Kawata Y, Sakiyama F, Hayashi F, Kyogoku Y: Identification of two essential histidine residues of ribonuclease T2 from Aspergillus oryzae. Eur J Biochem. 1990, 187: 255-262.View ArticlePubMedGoogle Scholar
  34. Campomenosi P, Salis S, Lindqvist C, Mariani D, Nordström T, Acquati F, Taramelli R: Characterization of RNASET2, the first human member of the Rh/T2/S family of glycoproteins. Arch Biochem Biophys. 2006, 449: 17-26.View ArticlePubMedGoogle Scholar
  35. Hunter CA: New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol. 2005, 5: 521-531.View ArticlePubMedGoogle Scholar
  36. Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG: Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol. 2011, 29: 71-109.View ArticlePubMedGoogle Scholar
  37. Maassen CBM, Boersma WJA, van Holten-Neelen C, Claassen E, Laman JD: Growth phase of orally administered Lactobacillus strains differentially affects IgG1/IgG2a ratio for soluble antigens: implications for vaccine development. Vaccine. 2003, 21: 2751-2757.View ArticlePubMedGoogle Scholar

Copyright

© Xu et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Advertisement